Skip to main content
. 2017 Mar 27;8(24):39087–39100. doi: 10.18632/oncotarget.16598

Figure 5. Association of CYP1B1 expression with clinicopathologic characteristics of PCa.

Figure 5

(A–C) CYP1B1 expression in PCa tissues. Immunohistochemical staining of CYP1B1 protein in PCa specimens. Representative images showing immunoreactive CYP1B1 in BPH and cancer tissues (magnification: ×200) (A). Summary of CYP1B1 immunostaining score. Staining intensity was assessed as described in Materials and Methods (B). CYP1B1 mRNA expression in microdissected prostate tissues (C). (D) Correlation of CYP1B1 expression with clinicopathological characteristics of patients with PCa. †Data was not available for some samples. *p<0.05; ***p<0.001 (E) Kaplan-Meier survival curves for overall survival of patients with PCa. p=0.0111.